Addition of ICB to SNDX-ms6352 and CTX resulting in sustained loss of TAMs, tumor cells and decreased PD-L1/PD-1 expression accompanied by B- and T cell residual TLSs. The gene discussed is PDCD1; the disease is neoplasm.